Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Jones

Showing results (271-280 of 589) with videos related to

Pageof 59
Sort By:
Acta Neuropathologica|July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variantsSonja Hutter, Rosario M Piro, David E Reuss, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Oncotarget|December 22, 2017
Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinomaFiebo J C Ten Kate, Lucia Suzuki, Lambert C J Dorssers, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Scientific Reports|February 7, 2024
Clinical and molecular study of radiation-induced gliomasKaterina Trkova, David Sumerauer, Adela Bubenikova, et al.
Oncotarget|July 5, 2016
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytomaSamantha Mascelli, Paolo Nozza, David T W Jones, et al.
Pageof 59

Showing results (271-280 of 589) with videos related to

Sort By:
Pageof 59
Acta Neuropathologica|July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variantsSonja Hutter, Rosario M Piro, David E Reuss, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Oncotarget|December 22, 2017
Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinomaFiebo J C Ten Kate, Lucia Suzuki, Lambert C J Dorssers, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Scientific Reports|February 7, 2024
Clinical and molecular study of radiation-induced gliomasKaterina Trkova, David Sumerauer, Adela Bubenikova, et al.
Oncotarget|July 5, 2016
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytomaSamantha Mascelli, Paolo Nozza, David T W Jones, et al.
Pageof 59